Pharmaceutics International, Inc.

Established in 1994 by founder Syed E. Abidi and based in Hunt Valley, US, Pharmaceutics International, Inc. (Pii) is a provider of a broad range of services that include formulation development, analytical testing, clinical trial manufacturing, and commercial-scale production. In March 2024, Pharmaceutics International, Inc.

raised USD 4. 25 million in Series H funding.  The series H funding values Pharmaceutics International, Inc. at USD 175.

21 million post-money. The company is led by CEO John Fowler. Pharmaceutics International, Inc. offers customized solutions for solubility and bioavailability enhancement, leveraging advanced techniques such as solid dispersions, nanoparticles, and spray drying.

The company also specializes in developing lyophilization cycles and handling highly potent active pharmaceutical ingredients (HPAPIs), including hormones and controlled substances. Additionally, the company offers comprehensive analytical services that support the drug development lifecycle, from concept to clinic to commercialization. The services include method development, validation, stability studies, and quality control testing. Pii offers phase-appropriate manufacturing solutions, including aseptic fill-finish, oral solid dose production, and the handling of highly viscous formulations, to manage the complexities of both small and large-scale production runs.

The firm also offered enhanced services, which include tech transfer, project management, and serialization, ensuring a seamless transition from development to manufacturing and compliance with regulatory requirements.